PDCD1 and neoplasm: Once the tumor volume reached 100 mm3 (day 14), the mice were administered oral RGE at a dose of 100 or 300 mg/kg every day, whereas Keytruda (hPD-1 antibody) was administered intraperitoneally at dose of 2.5 mg/kg twice a week.